Portfolio Holdings Detail for ISIN IE00B43HR379
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IHCU(GBX) LSE
ETF Ticker IUHC(USD) LSE
ETF Ticker QDVG(EUR) F
ETF Ticker IHCU.LS(GBX) CXE
ETF Ticker IUHC.LS(USD) CXE
ETF Ticker IUHCz(USD) CXE
ETF Ticker QDVG.DE(EUR) CXE
ETF Ticker IHCU.L(GBP) LSE
ETF Ticker IUHC.L(GBP) LSE

Holdings detail for VRTX

Stock Name	Vertex Pharmaceuticals Inc
Ticker	VRTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92532F1003
LEI	54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY: (RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Why This Biotech Company Could Be a Growth Stock Powerhouse: Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
3 Absurdly Cheap Stocks to Buy for the Long Haul: Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
My 2 Favorite Stocks to Buy Right Now: Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
Capital Group Growth ETF Experiences Big Inflow: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
2 Growth Stocks That Are No-Brainer Buys Right Now: Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
The Smartest Growth Stocks to Buy With $1,000 Right Now: Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
5 Top Stocks to Buy in August: Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
Wednesday's ETF with Unusual Volume: LSGR: The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day. Components of that ETF with the highest - 2025-08-06 13:11:25
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
Stocks Pressured by Disappointing US Service Sector News: The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-10-21 (Tuesday)	126,712	USD 54,013,524	USD 54,013,524	0	USD 908,525	USD 426.27	USD 419.1
2025-10-20 (Monday)	126,712	USD 53,104,999	USD 53,104,999	0	USD 290,170	USD 419.1	USD 416.81
2025-10-17 (Friday)	126,712	USD 52,814,829	USD 52,814,829	-572	USD 805,314	USD 416.81	USD 408.61
2025-10-16 (Thursday)	127,284	USD 52,009,515	USD 52,009,515	715	USD 382,020	USD 408.61	USD 407.9
2025-10-15 (Wednesday)	126,569	USD 51,627,495	USD 51,627,495	1,001	USD -134,146	USD 407.9	USD 412.22
2025-10-14 (Tuesday)	125,568	USD 51,761,641	USD 51,761,641	143	USD 667,259	USD 412.22	USD 407.37
2025-10-13 (Monday)	125,425	USD 51,094,382	USD 51,094,382
2025-10-08 (Wednesday)	123,995	USD 52,220,494	USD 52,220,494
2025-10-07 (Tuesday)	123,566	USD 50,696,658	USD 50,696,658	0	USD 911,917	USD 410.28	USD 402.9
2025-10-06 (Monday)	123,566	USD 49,784,741	USD 49,784,741	715	USD 238,933	USD 402.9	USD 403.3

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00B43HR379

Show aggregate share trades of VRTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-17 SELL -572 416.810* 455.90 Profit of 260,774 on sale
2025-10-16 BUY 715 408.610* 456.14
2025-10-15 BUY 1,001 407.900* 456.38
2025-10-14 BUY 143 412.220* 456.61
2025-10-06 BUY 715 402.900* 457.12
2025-10-03 BUY 282 403.300* 457.40
2025-10-02 BUY 141 408.850* 457.65
2025-10-01 BUY 822 404.210* 457.93
2025-09-24 BUY 480 376.620* 459.86
2025-09-18 BUY 140 387.110* 460.26
2025-09-11 BUY 140 397.370* 461.38
2025-09-10 BUY 140 388.550* 461.78
2025-08-28 BUY 140 392.050* 462.92
2025-08-26 BUY 560 387.180* 463.77
2025-08-20 BUY 280 394.360* 465.39
2025-08-19 BUY 140 390.760* 465.82
2025-07-17 SELL -142 463.270* 465.89 Profit of 66,157 on sale
2025-07-15 SELL -568 464.200* 465.88 Profit of 264,621 on sale
2025-07-14 SELL -1,420 472.350* 465.84 Profit of 661,497 on sale
2025-07-09 SELL -142 478.965* 465.66 Profit of 66,123 on sale
2025-07-07 SELL -284 459.410* 465.69 Profit of 132,257 on sale
2025-07-02 BUY 142 457.030* 465.83
2025-06-24 SELL -2,414 450.270* 466.51 Profit of 1,126,153 on sale
2025-06-23 BUY 142 443.540* 466.66
2025-06-20 BUY 815 440.870* 466.84
2025-06-18 SELL -141 448.400* 467.09 Profit of 65,859 on sale
2025-06-17 BUY 1,692 441.990* 467.26
2025-06-13 SELL -282 455.450* 467.45 Profit of 131,822 on sale
2025-06-11 SELL -141 452.440* 467.61 Profit of 65,933 on sale
2025-06-10 SELL -282 451.520* 467.73 Profit of 131,899 on sale
2025-06-09 SELL -423 446.150* 467.88 Profit of 197,913 on sale
2025-05-21 SELL -139 435.320* 470.47 Profit of 65,395 on sale
2025-05-20 SELL -278 447.180* 470.65 Profit of 130,842 on sale
2025-05-15 SELL -417 434.380* 471.45 Profit of 196,596 on sale
2025-05-14 SELL -417 421.160* 471.86 Profit of 196,767 on sale
2025-05-13 BUY 139 432.000* 472.19
2025-05-09 SELL -139 424.990* 472.87 Profit of 65,728 on sale
2025-05-08 BUY 278 429.600* 473.23
2025-05-01 BUY 278 498.860* 473.07
2025-04-24 SELL -139 492.470* 471.86 Profit of 65,588 on sale
2025-04-23 BUY 417 492.420* 471.67
2025-04-15 SELL -139 500.490* 470.65 Profit of 65,420 on sale
2025-04-10 SELL -278 475.490* 470.21 Profit of 130,717 on sale
2025-04-08 SELL -139 472.370* 470.06 Profit of 65,338 on sale
2025-04-07 SELL -139 474.560* 470.01 Profit of 65,331 on sale
2025-04-04 SELL -278 474.620* 469.96 Profit of 130,649 on sale
2025-04-02 BUY 139 483.490* 469.81
2025-04-01 BUY 1,251 484.740* 469.65
2025-03-31 SELL -834 484.820* 469.49 Profit of 391,551 on sale
2025-03-28 BUY 139 492.690* 469.23
2025-03-26 SELL -88 500.280* 468.50 Profit of 41,228 on sale
2025-03-21 BUY 973 503.200* 467.10
2025-03-20 BUY 556 510.180* 466.59
2025-03-17 SELL -139 513.760* 464.88 Profit of 64,618 on sale
2025-03-12 SELL -58 495.420* 463.49 Profit of 26,882 on sale
2025-03-07 BUY 139 488.290* 462.34
2025-02-28 SELL -417 479.790* 461.05 Profit of 192,257 on sale
2025-02-25 BUY 1,390 480.350* 460.30
2025-02-20 BUY 973 480.330* 459.29
2025-02-19 BUY 417 471.760* 459.10
2025-02-18 BUY 278 462.110* 459.05
2025-02-13 BUY 695 462.580* 459.00
2025-02-04 BUY 556 482.280* 457.36
2025-01-31 BUY 139 461.680* 457.02
2025-01-29 BUY 139 441.520* 457.72
2025-01-27 BUY 278 443.880* 458.37
2025-01-24 BUY 139 439.620* 458.78
2025-01-22 BUY 556 428.000* 459.91
2024-12-10 SELL -139 469.220* 472.58 Profit of 65,688 on sale
2024-12-09 SELL -3,614 473.980* 472.54 Profit of 1,707,741 on sale
2024-12-03 SELL -1,668 456.970* 474.22 Profit of 790,998 on sale
2024-12-02 SELL -695 465.730* 474.53 Profit of 329,801 on sale
2024-11-29 SELL -138 468.130* 474.78 Profit of 65,520 on sale
2024-11-22 SELL -1,380 450.970* 477.88 Profit of 659,470 on sale
2024-11-21 SELL -690 450.370* 479.25 Profit of 330,684 on sale
2024-11-20 BUY 1,104 451.230* 480.73
2024-11-18 SELL -1,656 467.010* 483.46 Profit of 800,608 on sale
2024-11-11 BUY 1,242 501.720* 481.81
2024-11-08 SELL -4,416 516.740* 479.31 Profit of 2,116,633 on sale
2024-11-07 SELL -276 502.450* 477.53 Profit of 131,798 on sale
2024-11-01 SELL -276 471.120* 474.49 Profit of 130,960 on sale
2024-10-31 SELL -552 475.980* 474.31 Profit of 261,818 on sale
2024-10-30 BUY 138 475.080* 474.20
2024-10-29 BUY 828 470.360* 474.84
2024-10-28 SELL -414 476.370* 474.53 Profit of 196,456 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-10-17	SELL	-572	416.810*	455.90 Profit of 260,774 on sale
2025-10-16	BUY	715	408.610*	456.14
2025-10-15	BUY	1,001	407.900*	456.38
2025-10-14	BUY	143	412.220*	456.61
2025-10-06	BUY	715	402.900*	457.12
2025-10-03	BUY	282	403.300*	457.40
2025-10-02	BUY	141	408.850*	457.65
2025-10-01	BUY	822	404.210*	457.93
2025-09-24	BUY	480	376.620*	459.86
2025-09-18	BUY	140	387.110*	460.26
2025-09-11	BUY	140	397.370*	461.38
2025-09-10	BUY	140	388.550*	461.78
2025-08-28	BUY	140	392.050*	462.92
2025-08-26	BUY	560	387.180*	463.77
2025-08-20	BUY	280	394.360*	465.39
2025-08-19	BUY	140	390.760*	465.82
2025-07-17	SELL	-142	463.270*	465.89 Profit of 66,157 on sale
2025-07-15	SELL	-568	464.200*	465.88 Profit of 264,621 on sale
2025-07-14	SELL	-1,420	472.350*	465.84 Profit of 661,497 on sale
2025-07-09	SELL	-142	478.965*	465.66 Profit of 66,123 on sale
2025-07-07	SELL	-284	459.410*	465.69 Profit of 132,257 on sale
2025-07-02	BUY	142	457.030*	465.83
2025-06-24	SELL	-2,414	450.270*	466.51 Profit of 1,126,153 on sale
2025-06-23	BUY	142	443.540*	466.66
2025-06-20	BUY	815	440.870*	466.84
2025-06-18	SELL	-141	448.400*	467.09 Profit of 65,859 on sale
2025-06-17	BUY	1,692	441.990*	467.26
2025-06-13	SELL	-282	455.450*	467.45 Profit of 131,822 on sale
2025-06-11	SELL	-141	452.440*	467.61 Profit of 65,933 on sale
2025-06-10	SELL	-282	451.520*	467.73 Profit of 131,899 on sale
2025-06-09	SELL	-423	446.150*	467.88 Profit of 197,913 on sale
2025-05-21	SELL	-139	435.320*	470.47 Profit of 65,395 on sale
2025-05-20	SELL	-278	447.180*	470.65 Profit of 130,842 on sale
2025-05-15	SELL	-417	434.380*	471.45 Profit of 196,596 on sale
2025-05-14	SELL	-417	421.160*	471.86 Profit of 196,767 on sale
2025-05-13	BUY	139	432.000*	472.19
2025-05-09	SELL	-139	424.990*	472.87 Profit of 65,728 on sale
2025-05-08	BUY	278	429.600*	473.23
2025-05-01	BUY	278	498.860*	473.07
2025-04-24	SELL	-139	492.470*	471.86 Profit of 65,588 on sale
2025-04-23	BUY	417	492.420*	471.67
2025-04-15	SELL	-139	500.490*	470.65 Profit of 65,420 on sale
2025-04-10	SELL	-278	475.490*	470.21 Profit of 130,717 on sale
2025-04-08	SELL	-139	472.370*	470.06 Profit of 65,338 on sale
2025-04-07	SELL	-139	474.560*	470.01 Profit of 65,331 on sale
2025-04-04	SELL	-278	474.620*	469.96 Profit of 130,649 on sale
2025-04-02	BUY	139	483.490*	469.81
2025-04-01	BUY	1,251	484.740*	469.65
2025-03-31	SELL	-834	484.820*	469.49 Profit of 391,551 on sale
2025-03-28	BUY	139	492.690*	469.23
2025-03-26	SELL	-88	500.280*	468.50 Profit of 41,228 on sale
2025-03-21	BUY	973	503.200*	467.10
2025-03-20	BUY	556	510.180*	466.59
2025-03-17	SELL	-139	513.760*	464.88 Profit of 64,618 on sale
2025-03-12	SELL	-58	495.420*	463.49 Profit of 26,882 on sale
2025-03-07	BUY	139	488.290*	462.34
2025-02-28	SELL	-417	479.790*	461.05 Profit of 192,257 on sale
2025-02-25	BUY	1,390	480.350*	460.30
2025-02-20	BUY	973	480.330*	459.29
2025-02-19	BUY	417	471.760*	459.10
2025-02-18	BUY	278	462.110*	459.05
2025-02-13	BUY	695	462.580*	459.00
2025-02-04	BUY	556	482.280*	457.36
2025-01-31	BUY	139	461.680*	457.02
2025-01-29	BUY	139	441.520*	457.72
2025-01-27	BUY	278	443.880*	458.37
2025-01-24	BUY	139	439.620*	458.78
2025-01-22	BUY	556	428.000*	459.91
2024-12-10	SELL	-139	469.220*	472.58 Profit of 65,688 on sale
2024-12-09	SELL	-3,614	473.980*	472.54 Profit of 1,707,741 on sale
2024-12-03	SELL	-1,668	456.970*	474.22 Profit of 790,998 on sale
2024-12-02	SELL	-695	465.730*	474.53 Profit of 329,801 on sale
2024-11-29	SELL	-138	468.130*	474.78 Profit of 65,520 on sale
2024-11-22	SELL	-1,380	450.970*	477.88 Profit of 659,470 on sale
2024-11-21	SELL	-690	450.370*	479.25 Profit of 330,684 on sale
2024-11-20	BUY	1,104	451.230*	480.73
2024-11-18	SELL	-1,656	467.010*	483.46 Profit of 800,608 on sale
2024-11-11	BUY	1,242	501.720*	481.81
2024-11-08	SELL	-4,416	516.740*	479.31 Profit of 2,116,633 on sale
2024-11-07	SELL	-276	502.450*	477.53 Profit of 131,798 on sale
2024-11-01	SELL	-276	471.120*	474.49 Profit of 130,960 on sale
2024-10-31	SELL	-552	475.980*	474.31 Profit of 261,818 on sale
2024-10-30	BUY	138	475.080*	474.20
2024-10-29	BUY	828	470.360*	474.84
2024-10-28	SELL	-414	476.370*	474.53 Profit of 196,456 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	253,408	88	822,586	30.8%
2025-09-18	262,277	45	831,580	31.5%
2025-09-17	158,866	890	1,012,591	15.7%
2025-09-16	233,484	702	769,823	30.3%
2025-09-15	385,606	97	605,410	63.7%
2025-09-12	198,306	54	325,925	60.8%
2025-09-11	217,651	160	455,823	47.7%
2025-09-10	441,550	65	640,409	68.9%
2025-09-09	216,563	711	395,377	54.8%
2025-09-08	285,371	226	594,102	48.0%
2025-09-05	209,916	9	413,663	50.7%
2025-09-04	236,777	2,164	365,713	64.7%
2025-09-03	212,085	7	457,751	46.3%
2025-09-02	318,587	425	689,371	46.2%
2025-08-29	136,055	7	344,317	39.5%
2025-08-28	189,040	229	437,536	43.2%
2025-08-27	204,685	373	919,772	22.3%
2025-08-26	195,209	380	616,641	31.7%
2025-08-25	205,216	929	405,536	50.6%
2025-08-22	187,538	366	477,729	39.3%
2025-08-21	357,256	454	694,264	51.5%
2025-08-20	304,195	196	620,591	49.0%
2025-08-19	193,253	370	598,168	32.3%
2025-08-18	197,043	357	581,908	33.9%
2025-08-15	213,454	413	509,240	41.9%
2025-08-14	299,335	536	798,768	37.5%
2025-08-13	342,897	6,746	694,047	49.4%
2025-08-12	361,071	536	689,425	52.4%
2025-08-11	478,787	177	1,141,772	41.9%
2025-08-08	382,688	480	1,467,480	26.1%
2025-08-07	802,775	500	1,747,924	45.9%
2025-08-06	1,070,384	29,978	2,256,489	47.4%
2025-08-05	2,087,742	66,027	4,981,303	41.9%
2025-08-04	329,631	253	766,131	43.0%
2025-08-01	290,545	239	729,079	39.9%
2025-07-31	227,826	151	513,336	44.4%
2025-07-30	134,793	234	361,144	37.3%
2025-07-29	124,474	331	372,446	33.4%
2025-07-28	125,989	264	519,868	24.2%
2025-07-25	136,582	104	432,897	31.6%
2025-07-24	144,869	169	321,736	45.0%
2025-07-23	182,307	1,460	370,788	49.2%
2025-07-22	193,759	402	450,155	43.0%
2025-07-21	174,382	14,621	318,671	54.7%
2025-07-18	203,357	10,091	296,802	68.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IHCU(GBX) LSE
ETF Ticker	IUHC(USD) LSE
ETF Ticker	QDVG(EUR) F
ETF Ticker	IHCU.LS(GBX) CXE
ETF Ticker	IUHC.LS(USD) CXE
ETF Ticker	IUHCz(USD) CXE
ETF Ticker	QDVG.DE(EUR) CXE
ETF Ticker	IHCU.L(GBP) LSE
ETF Ticker	IUHC.L(GBP) LSE